These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3286714)

  • 1. The what, why and how of hyperkinesis: implications for nursing.
    Porter LS
    J Adv Nurs; 1988 Mar; 13(2):229-36. PubMed ID: 3286714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactivity (attention-deficit disorder).
    Martin CA; Welsh RJ; McKay SE; Bareuther CM
    J Fam Pract; 1984 Sep; 19(3):367-9, 372-3, 376-7 passim. PubMed ID: 6381638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of methylphenidate and dextroamphetamine in hyperactivity in children.
    Solomons G
    J Iowa Med Soc; 1971 Nov; 61(11):658-61. PubMed ID: 4107192
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal brain Dysfunction.
    Schain RJ
    Curr Probl Pediatr; 1975 Aug; 5(10):3-30. PubMed ID: 1101714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
    Arnold LE; Christopher J; Huestis R; Smeltzer DJ
    Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD
    Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Minimal brain dysfunction].
    Ruel JM
    Vie Med Can Fr; 1974 Aug; 3(8):758-60. PubMed ID: 4410153
    [No Abstract]   [Full Text] [Related]  

  • 10. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 11. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR
    Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral medications for minimal brain dysfunction in children.
    Green RP; Scales SM; Rosser PL
    J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperactivity in children: types, diagosis, drug therapy, approaches to management.
    Howell MC; Rever GW; Scholl ML; Trowbridge F; Rutledge A
    Clin Pediatr (Phila); 1972 Jan; 11(1):30-9. PubMed ID: 5061326
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperactivity in children.
    Rie HE
    Am J Dis Child; 1975 Jul; 129(7):783-9. PubMed ID: 1146773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The learning-disabled or hyperactive child: diagnosis and treatment.
    Sulzbacher SI
    JAMA; 1975 Dec; 234(9):938-41. PubMed ID: 1242491
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Gross MD
    Pediatrics; 1976 Sep; 58(3):423-31. PubMed ID: 958770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the electroencephalogram accompanying the use of stimulant drugs (methylphenidate and dextroamphetamine) in hyperactive children.
    Surwillo WW
    Biol Psychiatry; 1977 Dec; 12(6):787-99. PubMed ID: 597528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.